Robert Gronke, PhDBiogen, Inc における Senior Principal Scientistスピーカー
プロフィール
Robert Gronke is a Senior Principal Scientist in the Antisense Oligonucleotide department at Biogen. For 36 years, he’s led the purification process development, CMC leadership, and new technology assessments for Biogen’s commercial ASO products Qalsody and Spinraza along with biological products AVONEX, PLEGRIDY, BENEPALI, plus more than 25 clinical products. Rob currently manages a group of 6 associate scientists.
Prior to joining Biogen, Inc., Dr. Gronke was a post-doctoral fellow in the Pharmacology Department at Merck. He holds a Ph.D. degree in Biochemistry from the University of Kansas, Lawrence Kansas and a BS degree in Biochemistry from Northern Illinois University.
アジェンダセッション
Chairperson’s Remarks: Track 1
, 1:40pmセッションを見るUnderstanding UF/DF Capabilities for Enhancing ASO Processing to Make a Liquid or Lyo API
, 1:45pmセッションを見る